Opioid Prescriber Education Mandate Could Be Added To User Fee Bill
This article was originally published in The Pink Sheet Daily
Sen. Rockefeller introduces amendment that would require 16 hours of training every three years to maintain DEA registration.
You may also be interested in...
FDA encourages physicians to take advantage of an educational program funded by sponsors of the analgesics as part of the REMS for extended-release opioid products, but only three programs were identified by the March 1 launch date, with Boston University taking the lead.
FDA and DEA continued to negotiate through the Office of National Drug Control Policy on a viable option for a mandatory prescriber education program, which would be a large burden for whichever agency gets the job.
By the third year of continuing medical education efforts, FDA expects 60% of those who wrote a prescription for a long-acting/extended-release opioid in 2011 to receive training.